A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...
DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...
Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI ( NASDAQ: TEM) as the stock took a ...
Key Takeaways Tempus AI's fourth-quarter results missed estimates as its costs increased.The medical technology firm's ...
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was up 12.7% on Wednesday after Needham & Company LLC raised their price target on the stock from $56.00 to $70.00. Needham & Company LLC currently has a ...
We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
In a regulatory filing, Tempus AI (TEM) disclosed that its CEO Eric Lefkofsky disposed of 3.24M shares of company stock in a series of ...
Completing its initial public offering on June 14, Tempus AI stock closed at $40.25, and while it rose above this mark from time to time in the second half of 2024, the stock ended the year on a sour ...
Tempus AI (NASDAQ: TEM) is utilizing artificial intelligence to deliver better healthcare outcomes. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...
We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.